Concepedia

R Mors

RM

2

Publications

349

Citations

2

H-Index

2001

Active since

Affiliations

Gefluc Languedoc Roussillon(Current)

R Mors is an author at Gefluc Languedoc Roussillon specializing in tumor biology, oncology, and cancer therapeutics.

Top concepts

MedicineOncologyPathologyPharmacologyBreast CancerTumor BiologyCancer TherapyImmunologyCancer ResearchPharmacotherapy

Publications per year

2001–2003

2

Publications

2

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

Thierry Petit, M. Wilt, Michel Velten et al. · European Journal of Cancer · 2003 · 272 citations

Breast Oncology, Breast Cancer Patients, Medicine +9

Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting.

Thierry Petit, Christian Borel, J.P. Ghnassia et al. · PubMed · 2001 · 77 citations

Surgical Oncology, Chemotherapy Response, Breast Oncology +14

Rows per page

1–2 of 2